2023
DOI: 10.3390/cells12232741
|View full text |Cite
|
Sign up to set email alerts
|

UBE3C Facilitates the ER-Associated and Peripheral Degradation of Misfolded CFTR

Yuka Kamada,
Hazuki Tateishi,
Uta Nakayamada
et al.

Abstract: The ubiquitin E3 ligase UBE3C promotes the proteasomal degradation of cytosolic proteins and endoplasmic reticulum (ER) membrane proteins. UBE3C is proposed to function downstream of the RNF185/MBRL ER-associated degradation (ERAD) branch, contributing to the ERAD of select membrane proteins. Here, we report that UBE3C facilitates the ERAD of misfolded CFTR, even in the absence of both RNF185 and its functional ortholog RNF5 (RNF5/185). Unlike RNF5/185, UBE3C had a limited impact on the ubiquitination of misfo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 57 publications
1
1
0
Order By: Relevance
“…Treatment with FR3 increased the steady-state level of ΔF508-CFTR-NLuc upon TEZ/ELX/IVA treatment (Figure 3A). The CHX chase revealed a continuous reduction in the NLuc signal, with a half-life of approximately 100 min, consistent with the reported half-life of mature ΔF508-CFTR (Taniguchi et al, 2022;Kamada et al, 2023) (Figures 3B,C). Interestingly, FR3 treatment, in a concentration-dependent manner, weakly but significantly reduced the degradation of mature Frontiers in Pharmacology frontiersin.org ΔF508-CFTR induced by TEZ/ELX/IVA treatment, thereby extending its half-life (Figures 3B-D).…”
Section: Fr3 Stabilizes δF508-nbd1 and The Mature Form Of δF508-cftrsupporting
confidence: 86%
See 1 more Smart Citation
“…Treatment with FR3 increased the steady-state level of ΔF508-CFTR-NLuc upon TEZ/ELX/IVA treatment (Figure 3A). The CHX chase revealed a continuous reduction in the NLuc signal, with a half-life of approximately 100 min, consistent with the reported half-life of mature ΔF508-CFTR (Taniguchi et al, 2022;Kamada et al, 2023) (Figures 3B,C). Interestingly, FR3 treatment, in a concentration-dependent manner, weakly but significantly reduced the degradation of mature Frontiers in Pharmacology frontiersin.org ΔF508-CFTR induced by TEZ/ELX/IVA treatment, thereby extending its half-life (Figures 3B-D).…”
Section: Fr3 Stabilizes δF508-nbd1 and The Mature Form Of δF508-cftrsupporting
confidence: 86%
“…The CFTR expressions in CFBE cells were induced by treating them with 1 μg/mL dox for 4 days. BEAS-2B cells stably expressing CFTR variants-HiBiT, ∆Y490-ABCB1-HiBiT, or G601S-hERG-HiBiT were established by lentivirus transduction as previously ( Taniguchi et al, 2022 ) and were cultured in Dulbecco’s Modified Eagle Medium (DMEM) (FUJIFILM Wako Pure Chemical Corporation) supplemented with 10% FBS and 10 μg/mL blasticidin S. The HiBiT tag was introduced to the extracellular region of CFTR (4 th extracellular loop), ABCB1 (1 st extracellular loop) ( Kamada et al, 2023 ) or hERG (1 st extracellular loop). The hERG-HiBiT was produced by replacing the extracellular HA tag ( Apaja et al, 2013 ) with the HiBiT tag by PCR-based mutagenesis.…”
Section: Methodsmentioning
confidence: 99%